Search research articles
Contact Us
Filters
Showing results (241-250 of 351) with videos related to
Page
of 36
Sort By:
Nature
|
November 10, 2009
The abscisic acid receptor PYR1 in complex with abscisic acid
Julia Santiago, Florine Dupeux, Adam Round, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1983
Apomorphine response and subtyping of schizophrenia
D V Jeste, S Zalcman, D R Weinberger, et al.
Annals of Neurology
|
September 1, 1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease
N R Cutler, J V Haxby, R Duara, et al.
Clinical Neuropharmacology
|
August 1, 1995
Pramipexole in patients with early Parkinson's disease
J P Hubble, W C Koller, N R Cutler, et al.
The Journal of Clinical Psychiatry
|
July 1, 1996
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms
J J Sramek, M Tansman, A Suri, et al.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2008
In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci
Ronald R Cutler, Michel Odent, Hussein Hajj-Ahmad, et al.
Psychopharmacology Bulletin
|
May 2, 1998
Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophrenia
J J Sramek, M A Eldon, E Posvar, et al.
Journal of Clinical Psychopharmacology
|
January 8, 2004
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
Edmund P Harrigan, Jeffrey J Miceli, Richard Anziano, et al.
Diabetes Care
|
March 29, 2003
Do all prepubertal years of diabetes duration contribute equally to diabetes complications?
Kim C Donaghue, Jan M Fairchild, Maria E Craig, et al.
Neurobiology of Aging
|
January 1, 1987
CSF and serum concentrations of albumin and IgG in Alzheimer's disease
A D Kay, C May, N M Papadopoulos, et al.
Page
of 36
Search research articles
Search
Showing results (241-250 of 351) with videos related to
Sort By:
Page
of 36
Nature
|
November 10, 2009
The abscisic acid receptor PYR1 in complex with abscisic acid
Julia Santiago, Florine Dupeux, Adam Round, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1983
Apomorphine response and subtyping of schizophrenia
D V Jeste, S Zalcman, D R Weinberger, et al.
Annals of Neurology
|
September 1, 1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease
N R Cutler, J V Haxby, R Duara, et al.
Clinical Neuropharmacology
|
August 1, 1995
Pramipexole in patients with early Parkinson's disease
J P Hubble, W C Koller, N R Cutler, et al.
The Journal of Clinical Psychiatry
|
July 1, 1996
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms
J J Sramek, M Tansman, A Suri, et al.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2008
In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci
Ronald R Cutler, Michel Odent, Hussein Hajj-Ahmad, et al.
Psychopharmacology Bulletin
|
May 2, 1998
Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophrenia
J J Sramek, M A Eldon, E Posvar, et al.
Journal of Clinical Psychopharmacology
|
January 8, 2004
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
Edmund P Harrigan, Jeffrey J Miceli, Richard Anziano, et al.
Diabetes Care
|
March 29, 2003
Do all prepubertal years of diabetes duration contribute equally to diabetes complications?
Kim C Donaghue, Jan M Fairchild, Maria E Craig, et al.
Neurobiology of Aging
|
January 1, 1987
CSF and serum concentrations of albumin and IgG in Alzheimer's disease
A D Kay, C May, N M Papadopoulos, et al.
Page
of 36